GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer

Colorectal cancer (CRC) is one of the most-deadly malignancies worldwide. Current therapeutic regimens for CRC patients are relatively generic, based primarily on disease type and stage, with littl...